European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with track changes
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Multi-stakeholder workshop on Pharmacogenomics, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 September 2024, 09:00 (CEST) to 24 September 2024, 17:00 (CEST)
Workplan 2023-2025: HMA-EMA joint Big Data Steering Group
Human medicines European public assessment report (EPAR): Duloxetine Mylan, duloxetine, Date of authorisation: 19/06/2015, Revision: 19, Status: Authorised
Guide to information on human medicines evaluated by European Medicines Agency: what the Agency publishes and when
EMA press briefing on EU actions to tackle shortages of GLP-1 receptor agonists, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 June 2024, 15:30 (CEST) to 26 June 2024, 16:15 (CEST)
Patient registries